Gilead Sciences, Inc.
Toll like receptor modulator compounds

Last updated:

Abstract:

This application relates generally to toll like receptor modulator compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR8), and methods of making and using them.

Status:
Grant
Type:

Utility

Filling date:

31 Aug 2017

Issue date:

6 Aug 2019